Colgate-Palmolive Company (CL) has been a popular choice among
FMCG stocks to buy, according to hedge funds. Despite this, some shares have been sold by entities like NatWest Group and Boston Trust Walden Corp. The company's leadership is poised to reveal a global strategy at an upcoming consumer conference.
Dividend investors are particularly interested in the company. However, PT was lowered to $93 at
Stifel causing some concern. Various firms such as Barclays and TD Cowen maintain a 'buy' rating on the stock, and a number of organizations have increased their holdings, such as Sumitomo Mitsui Trust Group and Welch Group LLC. The stock's Q4 2024 earnings call highlighted
strategic goals being surpassed. Despite this, there has been an adjustment of price targets by leading banks. CL’s stocks did take a downward turn recently. Critiques arose as Jim Cramer commented on the company's flat forecasts. However, CL remains among the
best dividend kings stock to invest in. Revenue records were smashed, achieving a $20B milestone, leading to a massive profit jump. The results of Q4 beat estimates, yet the stock position was reduced by CIBC World Market. Still,
Colgate-Palmolive remains a company to watch with a mixture of strong growth, price adjustments and significant shareholder transactions.
Colgate-Palmolive Company CL News Analytics from Wed, 11 Sep 2024 07:00:00 GMT to Sat, 08 Feb 2025 23:08:15 GMT -
Rating 2
- Innovation 0
- Information 6
- Rumor -4
